Views
ISPOR Diaries 2023
View
May 19, 2023
Updates on Over the Counter Monograph Reform in the CARES Act
View
May 10, 2023
The EU HTA Regulation
View
Apr 27, 2023
FTC Compliance Warning for Product Health Claims
The US Federal Trade Commission (FTC) has released a crucial notice on substantiating product health claims and ensuring fair endorsement and testimonials practices.
View
Apr 17, 2023
Cosmetics Industry Regulatory Updates
View
Apr 11, 2023
Is Patient Engagement in Regulatory Decisions at a Tipping Point?
View
Mar 22, 2023
HTA Reforms in Germany
View
Mar 7, 2023
Journey to Insight and Inspiration
Patient journeys are a cornerstone for comprehensive and powerful brand plans – they offer a window into insights that inspire meaningful actions. However, too often patient journeys as they are currently practiced leave much to be desired. We've developed a approach to patient journeys in rare diseases that is uniquely insightful.
View
Feb 27, 2023
Unsure About the EU HTA Regulation?
View
Feb 23, 2023
Opportunities for Enhanced Communication between Manufacturers and US Payers (Part 3)
In part three of our series, ‘Opportunities for Enhanced Communication between Manufacturers and US Payers’, our experts explore the tools manufacturers can use to communicate HCEI to payers, insights from the Food and Drug Administration (FDA) guidance on payer communications, and practical considerations to optimize these interactions.
View
Feb 6, 2023